Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy

American Heart Journal

Volumn 152, Issue 1, 2006, Pages 93.e1-93.e6

  Bonapace, Stefano ^a   Rossi, Andrea ^a   Cicoira, Mariantonietta ^a   Golia, Giorgio ^a   Zanolla, Luisa ^a   Franceschini, Lorenzo ^a   Conte, Luca ^a   Marino, Paolo ^a   Zardini, Piero ^a   Vassanelli, Corrado ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; COLLAGEN TYPE 3; COLLAGEN TYPE 3 PROPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; METOPROLOL; RAMIPRIL; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA DISEASE; AORTA STIFFNESS; ARTICLE; CONGESTIVE CARDIOMYOPATHY; DOPPLER FLOWMETRY; EXTRACELLULAR MATRIX; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HEART STROKE VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PULSE WAVE; RADIOIMMUNOASSAY; VASCULARIZATION;

EID: 33745653564     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.04.026     Document Type: Article

References (35)

1. Pepine C.J., Nichols W.W., and Conti C.R. Aortic input impedance in heart failure. Circulation 58 (1978) 460-465
2. Arnold J.M.O., Marchiori G.E., Imrie J.R., et al. Large artery function in patients with chronic heart failure. Circulation 84 (1991) 2418-2425
3. Carroll J.D., Shroff S., Wirth P., et al. Arterial mechanical properties in dilated cardiomyopathy. J Clin Invest 87 (1991) 1002-1009
4. Bonapace S., Rossi A., Cicoira M., et al. Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. Circulation 107 (2003) 1603-1608
5. Giannattasio C., Achilli F., Failla M., et al. Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade. J Am Coll Cardiol 39 (2002) 1275-1282
6. Nichols WW, O'Rourke MF. Vascular impedance. In: McDonald's blood flow in arteries: theoretical, experimental and clinical principles. 4th ed. London (UK): Edward Arnold. 1998:54-97, 243-83, 347-95.
7. Dobrin P.B., Baker W.H., and Gley W.C. Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. Arch Surg 119 (1984) 405-409
8. McCullagh K.G., Duance V.C., and Bishop K.A. The distribution of collagen types I, III and V (AB) in normal and atherosclerotic human aorta. J Pathol 130 (1980) 45-55
9. Risteli L., and Risteli J. Noninvasive methods for detection of organ fibrosis. In: Rojkind M. (Ed). Focus on connective tissue in health and disease (1990), CRC Press, Boca Raton (Fla) 61-98
10. Klappacher G., Franzen P., Haab D., et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic and ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 75 (1995) 913-918
11. Zannad F., Alla F., Dousset B., et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Circulation 102 (2000) 2700-2706
12. Diez J., Laviades C., Mayor G., et al. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 91 (1995) 1450-1456
13. Uusimaa P., Risteli J., Niemela M., et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 96 (1997) 2565-2572
14. Cicoira M., Rossi A., Bonapace S., et al. Independent and additional prognostic value of aminoterminal propetide of type III procollagen circulating levels in patients with chronic heart failure. J Card Fail 10 (2004) 403-411
15. Duprez D.A., De Buyzere M.L., Rietzschel E.R., et al. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. Eur J Heart 19 (1998) 1371-1376
16. Weber K.T., and Brilla C.G. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 83 (1991) 1849-1865
17. Sun Y., Ramires F.J., and Weber K.T. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 35 (1997) 138-147
18. Park J.B., and Schiffrin E.L. Cardiac and vascular fibrosis and hypertrophy in aldosterone infused rats: role of endothelin-1. Am J Hypertens 15 (2002) 164-169
19. Albaladejo P., Bouaziz H., Duriez M., et al. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 23 (1994) 74-82
20. Benetos A., Lacolley P., and Safar M.E. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 17 (1997) 1152-1156
21. Lacolley P., Safar M.E., Lucet B., et al. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol 37 (2001) 662-667
22. Hundley W.G., Kitzman D.W., Morgan T.M., et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 38 (2001) 796-801
23. Baguet J.P., Kingwell B.A., Dart A.L., et al. Analysis of the regional pulse wave velocity by Doppler: methodology and reproducibility. J Hum Hypertens 17 (2003) 407-412
24. Sullivan D.R., Marwick T.H., and Freedman S.B. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 119 (1990) 1262-1267
25. Ramsey M.W., Goodfellow J., Jones C.J., et al. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 92 (1995) 3212-3219
26. Levine T.B., Francis C.S., Goldsmith S.R., et al. Activity of the sympathetic nervous system renin-angiotensin system assessed by plasma hormone levels and their relationships to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49 (1982) 1659-1666
27. Guerin A.P., Blacher J., and Pannier B. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103 (2001) 987-992
28. Medley T.L., Cole T.J., Gatzka C.D., et al. Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease. Circulation 105 (2002) 810-815
29. Lombes M., Oblin M.E., Gasc J.M., et al. Immunohistochemical and biochemical evidence of a cardiovascular mineralcorticoid receptor. Circ Res 71 (1992) 503-510
30. Zelis R., Delea C.S., Coleman H.N., et al. Arterial sodium content in experimental congestive heart failure. Circulation 41 (1970) 213-216
31. Safar M.E., Thuilliez C., Richard V., et al. Pressure-independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res 46 (2000) 269-276
32. Bryant D., Becker L., Richardson J., et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97 (1998) 1340-1341
33. Lacolley P., Labat C., Pujol A., et al. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation 106 (2002) 2848-2853
34. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
35. Medley T.L., Kingwell B.A., Gatzka C.D., et al. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 92 (2003) 1254-1261